folic acid 0.25 MG / Lacticaseibacillus casei KE-99 15 MG Oral Powder

RxCUI
1923410
RxNorm name
folic acid 0.25 MG / Lacticaseibacillus casei KE-99 15 MG Oral Powder
Display name
Folic acid/Lacticaseibacillus casei (Oral Powder)
Full name
folic acid 0.25 MG / Lacticaseibacillus casei KE-99 15 MG Oral Powder
Term type
SCD
Status
Active
Strength
0.25-15 mg
Dose form
Pwdr
Route
Oral Powder
Updated
2026-10-27 19:32:27

RxNorm Status History#

Status
Active
Source
RXNORM
Current
YES
Release start
062017
Active start
062017
Multiple ingredient
YES
Branded
NO

Ingredients And Strength#

Ingredient, Strength, Base table
IngredientStrengthBaseBasis of strength
Lacticaseibacillus casei KE-9915 MG / 1 EACHLacticaseibacillus caseiLacticaseibacillus casei KE-99
folic acid0.25 MG / 1 EACHfolic acidfolic acid

Dose Form Concepts#

Dose form, RxCUI table
Dose formRxCUI
Oral Powder346289

Derived Ingredient Concepts#

Ingredient, RxCUI table
IngredientRxCUI
Lacticaseibacillus casei1592255
folic acid4511

Source Vocabulary Codes#

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 2 matching rows.

NDC11, Source, Active table
NDC11SourceActive
52747020901rxnav_ndcsyes
52747020928rxnav_historical

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 0 matching rows.

No records found.

Drug Classes#

Source, Class ID, Class table
SourceClass IDClassTypeRelationshipDrug concept
ATCB03BBFolic acid and derivativesATC1-4folic acid
ATCV04CXOther diagnostic agentsATC1-4folic acid
MEDRTD005492Folic AcidCHEMhas_ingredientfolic acid
MEDRTD000014Abnormalities, Drug-InducedDISEASEmay_treatLacticaseibacillus casei
MEDRTD000741Anemia, AplasticDISEASEci_withfolic acid
MEDRTD018798Anemia, Iron-DeficiencyDISEASEci_withfolic acid
MEDRTD000749Anemia, MegaloblasticDISEASEmay_treatfolic acid
MEDRTD000752Anemia, PerniciousDISEASEci_withfolic acid
MEDRTD004342Drug HypersensitivityDISEASEci_withfolic acid
MEDRTD004342Drug HypersensitivityDISEASEci_withLacticaseibacillus casei
MEDRTD005494Folic Acid DeficiencyDISEASEmay_preventfolic acid
MEDRTD005494Folic Acid DeficiencyDISEASEmay_treatfolic acid
MEDRTD016269Milk HypersensitivityDISEASEci_withLacticaseibacillus casei
MEDRTD009436Neural Tube DefectsDISEASEmay_preventfolic acid
MEDRTN0000000163Enzyme InteractionsMOAhas_moafolic acid
MEDRTN0000009915Unknown Cellular or Molecular InteractionMOAhas_moaLacticaseibacillus casei
MEDRTN0000008337Cellular Activity AlterationPEhas_pefolic acid
MEDRTN0000009925Unknown Physiological EffectPEhas_peLacticaseibacillus casei

Properties#

Category, Property, Value table
CategoryPropertyValue
ATTRIBUTESAVAILABLE_STRENGTH0.25 MG / 15 MG (expressed as Lacticaseibacillus casei KE-99)
ATTRIBUTESGENERAL_CARDINALITYMULTI
ATTRIBUTESHUMAN_DRUGUS
ATTRIBUTESRXNAV_HUMAN_DRUGUS
NAMESPrescribable Synonymfolic acid 250 MCG / Lactobacillus casei KE-99 15 MG Oral Powder
SOURCESSourceMicromedex RED BOOK